Sarah Derks

2.9k total citations
54 papers, 1.6k citations indexed

About

Sarah Derks is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Derks has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 26 papers in Oncology and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Derks's work include Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (21 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Sarah Derks is often cited by papers focused on Esophageal Cancer Research and Treatment (26 papers), Gastric Cancer Management and Outcomes (21 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Sarah Derks collaborates with scholars based in Netherlands, United States and Spain. Sarah Derks's co-authors include Manon van Engeland, James G. Herman, Adam J. Bass, Hanneke W.M. van Laarhoven, Gerrit A. Meijer, Adriaan P. de Bruı̈ne, Kim M. Smits, Gordon J. Freeman, Scott J. Rodig and Xiaoyun Liao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Sarah Derks

52 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Derks Netherlands	19	766	651	517	367	304	54	1.6k
Yuehong Cui China	21	530 0.7×	681 1.0×	370 0.7×	228 0.6×	145 0.5×	79	1.4k
Hongyong He China	22	784 1.0×	546 0.8×	490 0.9×	255 0.7×	106 0.3×	63	1.7k
Tomoyuki Momma Japan	23	539 0.7×	479 0.7×	242 0.5×	199 0.5×	179 0.6×	91	1.2k
Nam‐Yun Cho South Korea	23	661 0.9×	752 1.2×	220 0.4×	267 0.7×	407 1.3×	43	1.4k
Tingguo Zhang China	26	451 0.6×	626 1.0×	361 0.7×	404 1.1×	65 0.2×	67	1.5k
Karin Oien United Kingdom	19	482 0.6×	531 0.8×	479 0.9×	1.0k 2.7×	389 1.3×	27	1.9k
Mário Seixas Portugal	13	296 0.4×	414 0.6×	310 0.6×	421 1.1×	424 1.4×	19	1.0k
Koushiro Ohtsubo Japan	19	584 0.8×	452 0.7×	223 0.4×	319 0.9×	73 0.2×	69	1.1k
Stefania Beghelli Italy	19	1.4k 1.8×	503 0.8×	252 0.5×	377 1.0×	204 0.7×	32	2.0k
M Mai Japan	13	592 0.8×	491 0.8×	239 0.5×	173 0.5×	250 0.8×	22	1.1k

Countries citing papers authored by Sarah Derks

Since Specialization

Citations

This map shows the geographic impact of Sarah Derks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Derks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Derks more than expected).

Fields of papers citing papers by Sarah Derks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Derks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Derks. The network helps show where Sarah Derks may publish in the future.

Co-authorship network of co-authors of Sarah Derks

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Derks. A scholar is included among the top collaborators of Sarah Derks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Derks. Sarah Derks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silversmit, Geert, Philippe Nafteux, Camiel Rosman, et al.. (2025). Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison. International Journal of Cancer. 158(7). 1868–1880.

Chen, Li‐Ting, Myrthe Jager, Tom van den Ende, et al.. (2025). Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling. Genome Research. 35(4). 886–899. 3 indexed citations

May, Anne M., Antoine Adenis, Andreia Capela, et al.. (2025). Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study. European Journal of Cancer. 218. 115278–115278. 1 indexed citations

Verhoeven, Rob H.A., Marije Slingerland, Bas P. L. Wijnhoven, et al.. (2024). 438P Adjuvant nivolumab after neoadjuvant chemoradiotherapy and surgery for patients with esophageal or gastroesophageal junction cancer: A nationwide real-world matched comparison of overall survival. Annals of Oncology. 35. S176–S177. 1 indexed citations

King, Lisa A., Manon C. Slot, Derk Amsen, et al.. (2023). A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors. Cancer Immunology Research. 11(9). 1237–1252. 21 indexed citations

Ende, Tom van den, Ymke van der Pol, Aafke Creemers, et al.. (2023). Genome‐wide and panel‐based cell‐free DNA characterization of patients with resectable esophageal adenocarcinoma. The Journal of Pathology. 261(3). 286–297. 3 indexed citations

Borgstein, Alexander B.J., Wietse J. Eshuis, Kathelijn S. Versteeg, et al.. (2023). Neoadjuvant chemotherapy in older patients with gastric cancer undergoing surgery: a population-based cohort study. Gastric Cancer. 26(5). 763–774. 8 indexed citations

Lindblad, Mats, Mark I. van Berge Henegouwen, Wietse J. Eshuis, et al.. (2023). Diagnostic workup for esophageal cancer patients can be improved with checklists and clearer protocols; a comparative study between two tertiary centers in Europe. European Journal of Surgical Oncology. 50(2). 107318–107318. 1 indexed citations

Laarhoven, Hanneke W.M. van & Sarah Derks. (2023). The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma. Cell Reports Medicine. 4(4). 100990–100990. 1 indexed citations

10.

Derks, Sarah, et al.. (2022). Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review. Cancer Treatment Reviews. 108. 102418–102418. 30 indexed citations

11.

Klerk, Leonie K. de, Nicole C.T. van Grieken, Johanna W. van Sandick, et al.. (2021). Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies. Molecular Oncology. 15(4). 901–914. 9 indexed citations

12.

Ende, Tom van den, et al.. (2021). A systematic review of HER2 blockade for the curative treatment of gastroesophageal adenocarcinoma: Successes achieved and opportunities ahead. Cancer Treatment Reviews. 99. 102249–102249. 8 indexed citations

13.

Buffa, Francesca M., Kitty C. M. Castricum, Syed Haider, et al.. (2021). Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. Journal of Experimental & Clinical Cancer Research. 40(1). 161–161. 22 indexed citations

14.

Velzen, M.J.M. van, Willemieke P.M. Dijksterhuis, Marije Slingerland, et al.. (2021). The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer. European Journal of Cancer. 156. 60–69. 3 indexed citations

15.

Ende, Tom van den, Héctor G. van den Boorn, Faridi S. van Etten‐Jamaludin, et al.. (2020). Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1874(1). 188386–188386. 73 indexed citations

16.

Derks, Sarah, Katie S. Nason, Xiaoyun Liao, et al.. (2015). Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma. Cancer Immunology Research. 3(10). 1123–1129. 114 indexed citations

17.

Cleven, Arjen H.G., Sarah Derks, Muriel X.G. Draht, et al.. (2014). CHFR Promoter Methylation Indicates Poor Prognosis in Stage II Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 20(12). 3261–3271. 30 indexed citations

18.

Draht, Muriel X.G., Kim M. Smits, Valérie Jooste, et al.. (2014). Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. Molecular Oncology. 8(3). 679–688. 30 indexed citations

19.

Vlodrop, Iris J.H. van, Hanneke E.C. Niessen, Sarah Derks, et al.. (2011). Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!. Clinical Cancer Research. 17(13). 4225–4231. 113 indexed citations

20.

Derks, Sarah, Cindy Postma, Beatriz Carvalho, et al.. (2007). Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis. 29(2). 434–439. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact